Former Centrica CEO Iain Conn Among Candidates for IP Group Chair Position
Iain Conn, a former CEO of Centrica and an executive with extensive experience at BP, is being considered as a potential chairman of IP Group, the science investment firm. A decision is anticipated from IP Group's board before the year's end. The firm has backed several notable companies, including Hinge Health and Oxford Nanopore, and recently reported declines in the value of its holdings due to funding delays and pricing pressures.
Theia Market Signal Identification - AI Assisted
Iain Conn, the former CEO of Centrica and a seasoned executive with a decade-long tenure at BP, has emerged as a leading candidate to chair IP Group, a prominent early-stage science investment firm. Sources indicate that the decision regarding the new chairman is expected from IP Group's board by year-end, following the tenure of Sir Douglas Flint.
IP Group has a notable track record, having supported innovative companies such as Hinge Health and Oxford Nanopore. The firm recently reported its half-year results, which highlighted significant challenges, including funding delays and pricing pressures impacting the value of its holdings, which have seen a decline exceeding £35 million. As of Thursday, IP Group's shares traded at approximately 53p, reflecting a market capitalization nearing £500 million, underscoring the financial landscape in which the company operates.
Comments